Determining sensitivity to rapamycin and its analogues in breast cancer patients
about
Rapamycin induces the anti-apoptotic protein survivin in neuroblastoma.Serum and glucocorticoid-regulated kinase 1 (SGK1) activation in breast cancer: requirement for mTORC1 activity associates with ER-alpha expression.eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma.
P2860
Determining sensitivity to rapamycin and its analogues in breast cancer patients
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Determining sensitivity to rapamycin and its analogues in breast cancer patients
@ast
Determining sensitivity to rapamycin and its analogues in breast cancer patients
@en
Determining sensitivity to rapamycin and its analogues in breast cancer patients
@nl
type
label
Determining sensitivity to rapamycin and its analogues in breast cancer patients
@ast
Determining sensitivity to rapamycin and its analogues in breast cancer patients
@en
Determining sensitivity to rapamycin and its analogues in breast cancer patients
@nl
prefLabel
Determining sensitivity to rapamycin and its analogues in breast cancer patients
@ast
Determining sensitivity to rapamycin and its analogues in breast cancer patients
@en
Determining sensitivity to rapamycin and its analogues in breast cancer patients
@nl
P2860
P921
P356
P1476
Determining sensitivity to rapamycin and its analogues in breast cancer patients
@en
P2093
Caroline J Witton
P2860
P2888
P356
10.1186/BCR985
P407
P577
2004-12-17T00:00:00Z
P5875
P6179
1023480041